Cargando…
Pharmacogenetics and adhd treatment outcomes in the danish population-based IPSYCH sample
INTRODUCTION: Pharmacogenetics (PGx) studies genetic variance and related differences in drug outcomes. The aim of PGx testing is to increase therapy efficacy and safety, by applying e.g. dose adjustments in patients with a specific geno- or phenotype. PGx guidelines for psychotropic drugs are avail...
Autores principales: | Lunenburg, C., Ishtiak-Ahmed, K., Thirstrup, J., Gasse, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471865/ http://dx.doi.org/10.1192/j.eurpsy.2021.395 |
Ejemplares similares
-
Pharmacogenetics and antidepressant treatment outcomes in pregnancy: a Danish-population based study
por: Mushtaq, M., et al.
Publicado: (2022) -
Pharmacogenetic CYP2D6 variability, phenoconversion and treatment outcomes: A Danish population-based cohort study in 6,798 individuals initiating atomoxetine treatment
por: Ishtiak-Ahmed, K., et al.
Publicado: (2022) -
Pharmacogenetic profiles of young danish individuals with and without severe mental disorders
por: Lunenburg, C., et al.
Publicado: (2021) -
Pharmacogenetic drug use in young danish individuals with severe mental disorders
por: Lunenburg, C., et al.
Publicado: (2021) -
Clinical impact of functional CYP2C19 and CYP2D6 gene variants on treatment outcomes in patients with depression: a Danish cohort study
por: Thiele, L., et al.
Publicado: (2022)